6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Press Release Apr 29 2026
8m ago	UBS reports USD 3.0bn net profit and 16.8% RoCET1 in 1Q26 driven by strong client activity and flows; on track to complete integration by year-end (Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules)
35m ago	e.l.f. Cosmetics Joins the International Dance League as Founding Partner to Put Dancers Center Stage
1h ago	TDG Gold Appoints Paul Geddes as Senior Vice-President Business Development and Strategy
1h ago	Meryllion Resources Announces New Non-Brokered LIFE Financing

About

Allogene Therapeutics Inc (NASDAQ:ALLO) — investor relations, events, news, and company updates on 6ix.

Latest News

Allogene Therapeutics Expands Pivotal Phase 2 ALPHA3 Trial to South Korea and Australia

Allogene Therapeutics Showcases Momentum with Clinical and Platform Advancements in Allogeneic CAR T at AACR 2026

Allogene Therapeutics Announces Closing of $200.4 Million Public Offering of Common Stock

Allogene Therapeutics Announces Nature Communications Publication Highlighting Pre-Clinical Data for ALLO-329, a Next Generation Dual-Targeted CD19/CD70 Allogeneic CAR T for Autoimmune Diseases

Allogene Therapeutics Announces Pricing of Public Offering of Common Stock

Financials

Revenue

$0

Market Cap

$633.82 M

EPS

-0.87

Community Chat

Ask AI